Back to Journals » Cancer Management and Research » Volume 12

Efficacy and Safety of Anlotinib for Patients with Advanced NSCLC Who Progressed After Standard Regimens and the Preliminary Analysis of an Efficacy Predictor

Total article views   HTML views PDF downloads Totals
4,775 Dovepress* 4,270+ 788 5,058
PubMed Central* 505 178 683
Totals 4,775 966 5,741
*Since 12 July 2020
Total mentioned Facebook Delicious Reddit Twitter Others
14 0 0 0 3 11

View citations on PubMed Central and Google Scholar